SPY319.34+8.04 2.58%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Akero Therapeutics Q1 EPS $(0.420)

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.420) per share.

Benzinga · 05/13/2020 20:09

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.420) per share.